OVERALL AND CANCER-SPECIFIC SURVIVAL OF HIGH-RISK PROSTATE CANCER - IMPACT OF ADJUVANT THERAPY AFTER RADICAL PROSTATECTOMY

被引：0
|
作者：
Ganev, Tosho [1 ,2 ]
机构：
[1] Med Univ Varna, Fac Med, Dept Surg, MHAT Sveta Anna,Clin Urol, Varna, Bulgaria
[2] Med Univ Varna, Dept Surg, Clin Urol, MHAT Sveta Anna Varna, 100 Tzar Osvoboditel Blvd, Varna 9000, Bulgaria
来源：
JOURNAL OF IMAB | 2023年 / 29卷 / 04期
关键词：
hormonal therapy; radiotherapy; Gleason score; MULTIMODAL TREATMENT; SCORE;
D O I：
10.5272/jimab.2023294.5188
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Purpose: The study examines the survival of patients with high-risk prostate cancer in order to find a relationship between survival and the type of postoperative therapy.Materials/Methods: The object of the study were 872 patients who underwent radical prostatectomy in the Clinic of Urology in "St. Anna Varna" Hospital for the period from April 17, 1996, until November 25, 2022. Postoperatively, some patients were additionally subjected to hormonal therapy (referred to as "dual therapy" in the text), and others to hormonal and radiotherapy (referred to as "triple therapy").Results: Overall and cancer-specific survival of high risk patients did not differ statistically significantly for the two types of postoperative therapy.Conclusions: The optimal combination of radical prostatectomy, hormonal and radiotherapy in order to achieve maximum survival for patients with high-risk prostate cancer is still poorly defined.
引用
收藏
页码：5188 / 5191
页数：4
相关论文
共 50 条
  • [1] Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer
    Linder, Brian J.
    Boorjian, Stephen A.
    Umbreit, Eric C.
    Carlson, Rachel E.
    Rangel, Laureano J.
    Bergstralh, Eric J.
    Karnes, R. Jeffrey
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (08) : 798 - 805
  • [2] DOES HIGH-RISK PROSTATE CANCER HAVE WORSE SURVIVAL AFTER RADICAL PROSTATECTOMY?
    Ganev, Tosho
    JOURNAL OF IMAB, 2024, 30 (02): : 5486 - 5489
  • [3] Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer COMMENT
    Hall, Mary E.
    Stone, Benjamin V.
    Tosoian, Jeffrey J.
    JOURNAL OF UROLOGY, 2022, 207 (02) : 384 - 384
  • [4] Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
    Yossepowitch, Ofer
    Eggener, Scott E.
    Serio, Angel M.
    Caruer, Brett S.
    Bianco, Fernando J., Jr.
    Scardino, Peter T.
    Eastham, James A.
    EUROPEAN UROLOGY, 2008, 53 (05) : 950 - 959
  • [5] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Ingels, Alexandre
    de la Taille, Alexandre
    Ploussard, Guillaume
    CURRENT UROLOGY REPORTS, 2012, 13 (02) : 179 - 186
  • [6] Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
    Tsai, Henry K.
    Chen, Ming-Hui
    McLeod, David G.
    Carroll, Peter R.
    Richie, Jerome P.
    D'Amico, Anthony V.
    CANCER, 2006, 107 (11) : 2597 - 2603
  • [7] Adjuvant vs Salvage Radiation Therapy for High-Risk Prostate Cancer Following Radical Prostatectomy
    MacDuffie, Emily
    D'Amico, Anthony V.
    JAMA ONCOLOGY, 2020, 6 (08) : 1165 - 1166
  • [8] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Alexandre Ingels
    Alexandre de la Taille
    Guillaume Ploussard
    Current Urology Reports, 2012, 13 : 179 - 186
  • [9] Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer
    Ploussard, Guillaume
    Salomon, Laurent
    Allory, Yves
    Terry, Stephane
    Vordos, Dimitri
    Hoznek, Andreas
    Abbou, Claude-Clement
    Vacherot, Francis
    de la Taille, Alexandre
    BJU INTERNATIONAL, 2010, 106 (01) : 86 - 90
  • [10] Metastatic progression, cancer-specific mortality and need for secondary treatments in patients with clinically high-risk prostate cancer treated initially with radical prostatectomy
    Rubio-Briones, J.
    Iborra, I.
    Trassierra, M.
    Collado, A.
    Casanova, J.
    Gomez-Ferrer, A.
    Ricos, J. V.
    Monros, J. L.
    Dumont, R.
    Solsona, E.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (07): : 610 - 617
12345